Safety and Efficacy of BIA 5-1058 in PAH
NCT06009185
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG:
Oral zamicastat
Sponsor
Bial - Portela C S.A.